SEC filing record
Primary Source · SEC.gov

MAPS Public Benefit Corp

2023 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Raised

$215M

Investors

62

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

MAPS Public Benefit Corp is a Delaware entity that filed a Form D with the SEC on September 29, 2023 in the Pharmaceuticals industry group. The offering claims Rule 506(b) and covers equity. MAPS Public Benefit Corp reported $215,099,807 sold from 62 investors in an offering of indefinite size as of the Form D filed September 29, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names Cowen and Company, LLC (CRD 7616), associated with None; Big Path Capital LLC, associated with None as recipients of sales compensation soliciting in all states. The issuer's address of record is 3141 Stevens Creek Blvd, #40547, San Jose, CA 95117.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001995302
Entity NameMAPS Public Benefit Corp
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeOther
Jurisdiction of OrganizationDelaware
Issuer Address3141 Stevens Creek Blvd, #40547, San Jose, CA 95117
Phone(831) 429-6362
Industry / Fund TypePharmaceuticals
Securities TypeEquity
First Sale DateSeptember 15, 2023
Filing DateSeptember 29, 2023
Accession Number0001995302-23-000001
Total Offering AmountIndefinite
Total Amount Sold$215,099,807
Total Investors62
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Revenue RangeDecline to Disclose
State (Issuer Address)CA
Amendment CountOriginal filing only

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

0

none on file

Critical / warning

0 / 0

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

lapsed

Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Amy Emerson

Executive Officer, Director · San Jose, CA

Berra Yazar-Klosinski

Executive Officer · San Jose, CA

Andrew Septimus

Executive Officer · San Jose, CA

Michael Mullette

Executive Officer · San Jose, CA

Blair Clark-Schoeb

Executive Officer · San Jose, CA

Arman Nadershahi

Executive Officer · San Jose, CA

Jeffery George

Director · San Jose, CA

Daniel Grossman

Director · San Jose, CA

Gisselle Acevedo

Director · San Jose, CA

Jason Pyle

Director · San Jose, CA

Suprotik Basu

Director · San Jose, CA

Richard Doblin

Director · San Jose, CA

Dawn McCollough

Director · San Jose, CA

James Acer

Executive Officer · San Jose, CA

Placement Agents and Sales Compensation (Form D)

Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.

Cowen and Company, LLCCRD 7616 on BrokerCheck

Associated broker-dealer: None · New York, NY · Soliciting in all states

Big Path Capital LLC

Associated broker-dealer: None · Asheville, NC · Soliciting in all states

Questions About MAPS Public Benefit Corp

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is MAPS Public Benefit Corp?

MAPS Public Benefit Corp is a Delaware entity that filed a Form D with the SEC on September 29, 2023 in the Pharmaceuticals industry group. The filing claims Rule 506(b) for an offering of equity.

Is MAPS Public Benefit Corp legit?

AltStreet does not rate legitimacy; it reports the public record. MAPS Public Benefit Corp filed a Form D with the SEC on September 29, 2023 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $215,099,807 sold to 62 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is MAPS Public Benefit Corp registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that MAPS Public Benefit Corp claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has MAPS Public Benefit Corp raised?

MAPS Public Benefit Corp reported $215,099,807 sold from 62 investors in an offering of indefinite size as of the Form D filed September 29, 2023.

Who can invest in MAPS Public Benefit Corp?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in MAPS Public Benefit Corp?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling MAPS Public Benefit Corp and how are they paid?

The Form D names Cowen and Company, LLC (CRD 7616), associated with None; Big Path Capital LLC, associated with None as recipients of sales compensation soliciting in all states.

Who is behind MAPS Public Benefit Corp?

The Form D lists 14 related persons: Amy Emerson, executive officer, director; Berra Yazar-Klosinski, executive officer; Andrew Septimus, executive officer; Michael Mullette, executive officer; Blair Clark-Schoeb, executive officer; Arman Nadershahi, executive officer; Jeffery George, director; Daniel Grossman, director, and 6 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is MAPS Public Benefit Corp located?

The issuer's address on its SEC filings is 3141 Stevens Creek Blvd, #40547, San Jose, CA 95117. Its phone number of record is 831-429-6362. It is organized under the laws of Delaware.

How long is the MAPS Public Benefit Corp offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

What is MAPS Public Benefit Corp's revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.